A recent development in inhaler technology has been the development of low-velocity sprays known as soft mist inhalers. These devices represent a new class of multidose inhaler devices and contain liquid formulations similar to those in nebulizers.
The global Drug Delivery Soft Mist Inhalers market size is projected to grow from US$ 2749 million in 2024 to US$ 4133 million in 2030; it is expected to grow at a CAGR of 7.0% from 2024 to 2030.
The 鈥淒rug Delivery Soft Mist Inhalers Industry Forecast鈥� looks at past sales and reviews total world Drug Delivery Soft Mist Inhalers sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug Delivery Soft Mist Inhalers sales for 2024 through 2030. With Drug Delivery Soft Mist Inhalers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Delivery Soft Mist Inhalers industry.
This Insight Report provides a comprehensive analysis of the global Drug Delivery Soft Mist Inhalers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Delivery Soft Mist Inhalers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Delivery Soft Mist Inhalers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Delivery Soft Mist Inhalers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Delivery Soft Mist Inhalers.
The growing incidence of chronic respiratory diseases, including asthma and COPD, along with the need for more effective inhalation delivery methods, is predicted to drive a fast growth in the global soft mist inhaler (Respimat, SMI) market in the following years. Growing demand for economically cost solutions and growing awareness of its advantages are expected to drive the SMI technology sector. Another factor predicted to boost market expansion is the launch of state-of-the-art and creative SMI products that provide patients with more comfort and convenience. For instance, by 2022, 11.7 million Americans, or 4.6% of the US population, will have chronic bronchitis, emphysema, or chronic obstructive lung disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Delivery Soft Mist Inhalers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Disposable
Reusable
Segmentation by Application:
Hospitals and Clinics
Homecare Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Recipharm (Resyca)
Boehringer
Merxin Ltd
DSB Medical Co., Ltd.
Aero Pump GmbH
Ursatec GmbH
3M
Hovione
Mannkind
Meda
Novartis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug Delivery Soft Mist Inhalers market?
What factors are driving Drug Delivery Soft Mist Inhalers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Delivery Soft Mist Inhalers market opportunities vary by end market size?
How does Drug Delivery Soft Mist Inhalers break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Delivery Soft Mist Inhalers Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Drug Delivery Soft Mist Inhalers by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Drug Delivery Soft Mist Inhalers by Country/Region, 2019, 2023 & 2030
2.2 Drug Delivery Soft Mist Inhalers Segment by Type
2.2.1 Disposable
2.2.2 Reusable
2.3 Drug Delivery Soft Mist Inhalers Sales by Type
2.3.1 Global Drug Delivery Soft Mist Inhalers Sales Market Share by Type (2019-2024)
2.3.2 Global Drug Delivery Soft Mist Inhalers Revenue and Market Share by Type (2019-2024)
2.3.3 Global Drug Delivery Soft Mist Inhalers Sale Price by Type (2019-2024)
2.4 Drug Delivery Soft Mist Inhalers Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare Settings
2.4.3 Others
2.5 Drug Delivery Soft Mist Inhalers Sales by Application
2.5.1 Global Drug Delivery Soft Mist Inhalers Sale Market Share by Application (2019-2024)
2.5.2 Global Drug Delivery Soft Mist Inhalers Revenue and Market Share by Application (2019-2024)
2.5.3 Global Drug Delivery Soft Mist Inhalers Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Drug Delivery Soft Mist Inhalers Breakdown Data by Company
3.1.1 Global Drug Delivery Soft Mist Inhalers Annual Sales by Company (2019-2024)
3.1.2 Global Drug Delivery Soft Mist Inhalers Sales Market Share by Company (2019-2024)
3.2 Global Drug Delivery Soft Mist Inhalers Annual Revenue by Company (2019-2024)
3.2.1 Global Drug Delivery Soft Mist Inhalers Revenue by Company (2019-2024)
3.2.2 Global Drug Delivery Soft Mist Inhalers Revenue Market Share by Company (2019-2024)
3.3 Global Drug Delivery Soft Mist Inhalers Sale Price by Company
3.4 Key Manufacturers Drug Delivery Soft Mist Inhalers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Delivery Soft Mist Inhalers Product Location Distribution
3.4.2 Players Drug Delivery Soft Mist Inhalers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Drug Delivery Soft Mist Inhalers by Geographic Region
4.1 World Historic Drug Delivery Soft Mist Inhalers Market Size by Geographic Region (2019-2024)
4.1.1 Global Drug Delivery Soft Mist Inhalers Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Drug Delivery Soft Mist Inhalers Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Drug Delivery Soft Mist Inhalers Market Size by Country/Region (2019-2024)
4.2.1 Global Drug Delivery Soft Mist Inhalers Annual Sales by Country/Region (2019-2024)
4.2.2 Global Drug Delivery Soft Mist Inhalers Annual Revenue by Country/Region (2019-2024)
4.3 Americas Drug Delivery Soft Mist Inhalers Sales Growth
4.4 APAC Drug Delivery Soft Mist Inhalers Sales Growth
4.5 Europe Drug Delivery Soft Mist Inhalers Sales Growth
4.6 Middle East & Africa Drug Delivery Soft Mist Inhalers Sales Growth
5 Americas
5.1 Americas Drug Delivery Soft Mist Inhalers Sales by Country
5.1.1 Americas Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024)
5.1.2 Americas Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024)
5.2 Americas Drug Delivery Soft Mist Inhalers Sales by Type (2019-2024)
5.3 Americas Drug Delivery Soft Mist Inhalers Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Delivery Soft Mist Inhalers Sales by Region
6.1.1 APAC Drug Delivery Soft Mist Inhalers Sales by Region (2019-2024)
6.1.2 APAC Drug Delivery Soft Mist Inhalers Revenue by Region (2019-2024)
6.2 APAC Drug Delivery Soft Mist Inhalers Sales by Type (2019-2024)
6.3 APAC Drug Delivery Soft Mist Inhalers Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug Delivery Soft Mist Inhalers by Country
7.1.1 Europe Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024)
7.1.2 Europe Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024)
7.2 Europe Drug Delivery Soft Mist Inhalers Sales by Type (2019-2024)
7.3 Europe Drug Delivery Soft Mist Inhalers Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Delivery Soft Mist Inhalers by Country
8.1.1 Middle East & Africa Drug Delivery Soft Mist Inhalers Sales by Country (2019-2024)
8.1.2 Middle East & Africa Drug Delivery Soft Mist Inhalers Revenue by Country (2019-2024)
8.2 Middle East & Africa Drug Delivery Soft Mist Inhalers Sales by Type (2019-2024)
8.3 Middle East & Africa Drug Delivery Soft Mist Inhalers Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Delivery Soft Mist Inhalers
10.3 Manufacturing Process Analysis of Drug Delivery Soft Mist Inhalers
10.4 Industry Chain Structure of Drug Delivery Soft Mist Inhalers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Delivery Soft Mist Inhalers Distributors
11.3 Drug Delivery Soft Mist Inhalers Customer
12 World Forecast Review for Drug Delivery Soft Mist Inhalers by Geographic Region
12.1 Global Drug Delivery Soft Mist Inhalers Market Size Forecast by Region
12.1.1 Global Drug Delivery Soft Mist Inhalers Forecast by Region (2025-2030)
12.1.2 Global Drug Delivery Soft Mist Inhalers Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Drug Delivery Soft Mist Inhalers Forecast by Type (2025-2030)
12.7 Global Drug Delivery Soft Mist Inhalers Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Recipharm (Resyca)
13.1.1 Recipharm (Resyca) Company Information
13.1.2 Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.1.3 Recipharm (Resyca) Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Recipharm (Resyca) Main Business Overview
13.1.5 Recipharm (Resyca) Latest Developments
13.2 Boehringer
13.2.1 Boehringer Company Information
13.2.2 Boehringer Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.2.3 Boehringer Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Main Business Overview
13.2.5 Boehringer Latest Developments
13.3 Merxin Ltd
13.3.1 Merxin Ltd Company Information
13.3.2 Merxin Ltd Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.3.3 Merxin Ltd Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merxin Ltd Main Business Overview
13.3.5 Merxin Ltd Latest Developments
13.4 DSB Medical Co., Ltd.
13.4.1 DSB Medical Co., Ltd. Company Information
13.4.2 DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.4.3 DSB Medical Co., Ltd. Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 DSB Medical Co., Ltd. Main Business Overview
13.4.5 DSB Medical Co., Ltd. Latest Developments
13.5 Aero Pump GmbH
13.5.1 Aero Pump GmbH Company Information
13.5.2 Aero Pump GmbH Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.5.3 Aero Pump GmbH Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Aero Pump GmbH Main Business Overview
13.5.5 Aero Pump GmbH Latest Developments
13.6 Ursatec GmbH
13.6.1 Ursatec GmbH Company Information
13.6.2 Ursatec GmbH Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.6.3 Ursatec GmbH Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ursatec GmbH Main Business Overview
13.6.5 Ursatec GmbH Latest Developments
13.7 3M
13.7.1 3M Company Information
13.7.2 3M Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.7.3 3M Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 3M Main Business Overview
13.7.5 3M Latest Developments
13.8 Hovione
13.8.1 Hovione Company Information
13.8.2 Hovione Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.8.3 Hovione Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hovione Main Business Overview
13.8.5 Hovione Latest Developments
13.9 Mannkind
13.9.1 Mannkind Company Information
13.9.2 Mannkind Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.9.3 Mannkind Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mannkind Main Business Overview
13.9.5 Mannkind Latest Developments
13.10 Meda
13.10.1 Meda Company Information
13.10.2 Meda Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.10.3 Meda Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Meda Main Business Overview
13.10.5 Meda Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Drug Delivery Soft Mist Inhalers Product Portfolios and Specifications
13.11.3 Novartis Drug Delivery Soft Mist Inhalers Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
